JD.com Q2 Earnings: What to Expect and Analyst's Take

JD.com is set to report Q2 earnings on Thursday, August 14. Analysts expect EPS to decline 60% YoY to $0.97, while revenues are expected to rise 16% to $46.6 billion. Investors will look for commentary on tariffs, JD.com's growth in food delivery, and AI-related tailwinds. Citi analyst Alicia Yap has a Buy rating with a $42 price target, implying a 34.7% upside potential. Wall Street has a Moderate Buy consensus rating with an average price target of $42.13, implying a 31.16% upside potential.

JD.com, Inc. (NASDAQ: JD) is scheduled to release its second-quarter 2025 earnings on Thursday, August 14. Analysts expect earnings per share (EPS) to decline by 60% year-over-year (YoY) to $0.97, while revenues are anticipated to rise by 16% to $46.6 billion [1]. Investors will closely watch for commentary on tariffs, JD.com's growth in the food delivery sector, and the potential impact of AI-related investments.

The Zacks Consensus Estimate for JD's second-quarter revenues is pegged at $46.93 billion, indicating 17.03% year-over-year growth. The consensus mark for earnings is pegged at 50 cents per share, which has plunged 27 cents over the past 30 days. JD reported earnings of $1.29 per share in the year-ago quarter [1].

Key factors to note for JD’s Q2 earnings include the impact of the annual 618 Shopping Festival, which provided revenue support across various categories. The food delivery business, which approached 20 million daily orders by the end of the first quarter, is expected to have contributed incremental top-line growth during the quarter. However, elevated marketing expenditures and significant investments in AI technology infrastructure may have weighed on profitability [1].

The quarter's results will likely reflect JD's struggle to balance growth investments and competitive pressures against profitability targets, testing the sustainability of recent margin improvement trends amid an uncertain economic backdrop. Citi analyst Alicia Yap has a Buy rating with a $42 price target, implying a 34.7% upside potential. Wall Street has a Moderate Buy consensus rating with an average price target of $42.13, implying a 31.16% upside potential [1].

Investors will also look for updates on JD Health's competition in the online pharmaceutical sector and JD Logistics' costs from automation upgrades and capacity expansion. The broader Chinese consumer environment presented ongoing challenges, with macroeconomic headwinds expected to have offset some benefits from government stimulus measures [1].

References:
[1] https://www.tradingview.com/news/zacks:eeaad0a10094b:0-jd-com-set-to-report-q2-earnings-what-s-in-store-for-the-stock/